Boundless Bio to Present at the Citi 15th Annual BioPharma Virtual Conference

September 3, 2020 |

1 min read

Boundless Bio , a company developing innovative new therapies directed to extrachromosomal DNA (ecDNA) in aggressive cancers, today announced it will present a corporate overview at Citi’s 15th Annual BioPharma Virtual Conference. Date: Tuesday, September 8th Time: 4:40 p.m. EDT Presenter: Zachary Hornby, President and Chief Executive Officer of Boundless Bio About Boundless Bio Boundless Bio is a

Sept. 3, 2020 13:00 UTC

SAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a company developing innovative new therapies directed to extrachromosomal DNA (ecDNA) in aggressive cancers, today announced it will present a corporate overview at Citi’s 15th Annual BioPharma Virtual Conference.

Date: Tuesday, September 8th
Time: 4:40 p.m. EDT
Presenter: Zachary Hornby, President and Chief Executive Officer of Boundless Bio

About Boundless Bio

Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers.

For more information, visit www.boundlessbio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200903005213/en/

Contacts

Sarah Sutton
Glover Park Group
ssutton@gpg.com
202-337-0808

Danielle Cantey
Glover Park Group
dcantey@gpg.com
202-337-0808

Source: Boundless Bio

View this news release online at:
http://www.businesswire.com/news/home/20200903005213/en

Events